US consumer trends: skin-health ingredients in 2026
US shoppers increasingly buy skin care for skin health rather than cover-up. These are the ingredient themes shaping briefs, and what each means when you formulate and make claims.
Executive summary
US shoppers are buying skin care for skin health: barrier repair, microbiome-friendly formulas, gentler actives, body care with face-grade ingredients and everyday SPF. Each trend needs matching evidence and MoCRA compliance.
Take-home message for manufacturers
- Formulate gentler actives for tolerance, not just potency
- Test body formats in final pack sizes
- Treat SPF products as OTC drugs in the US
Barrier repair
Ceramides, cholesterol and fatty acids, panthenol and niacinamide are now expected in moisturisers, not just niche products. Back “barrier” claims with TEWL measurements rather than ingredient stories.
Microbiome-friendly
Prebiotics, postbiotic lysates and ferments are moving into mainstream ranges. There is no legal definition of “microbiome-friendly”, so match the wording to the strength of your data.
Gentler actives
Shoppers want results without irritation: retinal and encapsulated retinol, bakuchiol, azelaic acid and tranexamic acid. Formulate for tolerance and prove it with in-use studies on sensitive skin.
Skin care for the body
Face-grade actives are moving into body lotions and washes. Larger packs change stability, preservation and cost, so test in the final pack size.
Everyday sun protection
Daily SPF in moisturisers and tints remains strong. In the US these are OTC drugs, which shapes the filter choice and the testing.
A regulatory note
Every one of these products needs MoCRA compliance: facility registration, product listing, safety substantiation and adverse event reporting. Read our MoCRA guide.
Questions readers ask
Is “microbiome-friendly” a regulated claim?
There is no legal definition yet, so the wording should match the strength of your evidence.
Are daily SPF moisturisers cosmetics in the US?
No. Products with SPF claims are OTC drugs in the US.
Need help with this?
Our product, testing and regulatory teams work on this every week.
This article is general information, not legal advice.
